| __timestamp | Alpine Immune Sciences, Inc. | Galapagos NV |
|---|---|---|
| Wednesday, January 1, 2014 | 12199547 | 111110000 |
| Thursday, January 1, 2015 | 16054000 | 129714000 |
| Friday, January 1, 2016 | 23316000 | 139574000 |
| Sunday, January 1, 2017 | 10626000 | 218502000 |
| Monday, January 1, 2018 | 28970000 | 322876000 |
| Tuesday, January 1, 2019 | 35847000 | 427320000 |
| Wednesday, January 1, 2020 | 27185000 | 523667000 |
| Friday, January 1, 2021 | 58742000 | 491707000 |
| Saturday, January 1, 2022 | 70243000 | 515083000 |
| Sunday, January 1, 2023 | 80904000 | 241294000 |
Unveiling the hidden dimensions of data
In the ever-evolving world of biotechnology, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Alpine Immune Sciences, Inc. and Galapagos NV have demonstrated contrasting approaches to R&D investment.
From 2014 to 2023, Galapagos NV consistently outspent Alpine Immune Sciences, with R&D expenses peaking in 2020 at over 500% more than Alpine's. However, Alpine has shown a remarkable growth trajectory, increasing its R&D spending by approximately 560% from 2014 to 2023.
While Galapagos NV's R&D spending saw fluctuations, Alpine's steady increase suggests a strategic focus on innovation. In 2023, Alpine's R&D expenses reached 80% of Galapagos's, highlighting its growing emphasis on research. This trend underscores the dynamic nature of the biotech industry, where strategic investments can shift competitive landscapes.
Comparing Innovation Spending: Gilead Sciences, Inc. and Galapagos NV
Zoetis Inc. or Alpine Immune Sciences, Inc.: Who Invests More in Innovation?
Research and Development Expenses Breakdown: Regeneron Pharmaceuticals, Inc. vs Alpine Immune Sciences, Inc.
Research and Development Investment: Teva Pharmaceutical Industries Limited vs Galapagos NV
R&D Insights: How Incyte Corporation and Alpine Immune Sciences, Inc. Allocate Funds
R&D Spending Showdown: Madrigal Pharmaceuticals, Inc. vs Galapagos NV
Research and Development Investment: Axsome Therapeutics, Inc. vs Alpine Immune Sciences, Inc.
R&D Spending Showdown: Alpine Immune Sciences, Inc. vs CymaBay Therapeutics, Inc.
Comparing Innovation Spending: Alpine Immune Sciences, Inc. and Amicus Therapeutics, Inc.
Research and Development Expenses Breakdown: Alpine Immune Sciences, Inc. vs Viridian Therapeutics, Inc.
ACADIA Pharmaceuticals Inc. vs Galapagos NV: Strategic Focus on R&D Spending
R&D Spending Showdown: Mesoblast Limited vs Galapagos NV